nabumetone

Generic: nabumetone

Labeler: sciegen pharmaceuticals inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name nabumetone
Generic Name nabumetone
Labeler sciegen pharmaceuticals inc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

nabumetone 750 mg/1

Manufacturer
ScieGen Pharmaceuticals Inc

Identifiers & Regulatory

Product NDC 50228-466
Product ID 50228-466_2b9b03ef-e03c-eca1-e063-6394a90a3fad
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078420
Listing Expiration 2026-12-31
Marketing Start 2019-06-26

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50228466
Hyphenated Format 50228-466

Supplemental Identifiers

RxCUI
311892 311893
UPC
0350228466011 0350228466059 0350228465014
UNII
LW0TIW155Z
NUI
N0000000160 M0001335 N0000175722

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nabumetone (source: ndc)
Generic Name nabumetone (source: ndc)
Application Number ANDA078420 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 750 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (50228-466-01)
  • 500 TABLET in 1 BOTTLE (50228-466-05)
  • 30 TABLET in 1 BOTTLE (50228-466-30)
source: ndc

Packages (3)

50228-466-01 100 TABLET in 1 BOTTLE (50228-466-01) 50228-466-05 500 TABLET in 1 BOTTLE (50228-466-05) 50228-466-30 30 TABLET in 1 BOTTLE (50228-466-30)

Ingredients (1)

nabumetone (750 mg/1)

Linked Drug Pages (1)

Nabumetone ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2b9b03ef-e03c-eca1-e063-6394a90a3fad", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0350228466011", "0350228466059", "0350228465014"], "unii": ["LW0TIW155Z"], "rxcui": ["311892", "311893"], "spl_set_id": ["80c6888d-03b4-44f3-b94d-bcf5154ceae5"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["ScieGen Pharmaceuticals Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (50228-466-01)", "package_ndc": "50228-466-01", "marketing_start_date": "20190626"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (50228-466-05)", "package_ndc": "50228-466-05", "marketing_start_date": "20190626"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50228-466-30)", "package_ndc": "50228-466-30", "marketing_start_date": "20190626"}], "brand_name": "Nabumetone", "product_id": "50228-466_2b9b03ef-e03c-eca1-e063-6394a90a3fad", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "50228-466", "generic_name": "Nabumetone", "labeler_name": "ScieGen Pharmaceuticals Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nabumetone", "active_ingredients": [{"name": "NABUMETONE", "strength": "750 mg/1"}], "application_number": "ANDA078420", "marketing_category": "ANDA", "marketing_start_date": "20190626", "listing_expiration_date": "20261231"}